Kim Kelderman - 05 Aug 2023 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
05 Aug 2023
Net transactions value
-$340,102
Form type
4
Filing time
08 Aug 2023, 17:28:37 UTC
Previous filing
25 Aug 2022
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +8,060 +53% $0.000000 23,264 05 Aug 2023 Direct
transaction TECH Common Stock Tax liability $340,102 -4,139 -18% $82.17 19,125 05 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -8,060 -100% $0.000000* 0 05 Aug 2023 Common Stock 8,060 Direct F2, F3
holding TECH Stock Option (Right to Buy) 27,392 05 Aug 2023 Common Stock 27,392 $37.70 Direct F1
holding TECH Stock Option (Right to Buy) 48,176 05 Aug 2023 Common Stock 48,176 $44.33 Direct F1
holding TECH Stock Option (Right to Buy) 36,132 05 Aug 2023 Common Stock 36,132 $44.33 Direct F1
holding TECH Stock Option (Right to Buy) 47,844 05 Aug 2023 Common Stock 47,844 $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 63,792 05 Aug 2023 Common Stock 63,792 $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 35,964 05 Aug 2023 Common Stock 35,964 $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 33,300 05 Aug 2023 Common Stock 33,300 $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 47,952 05 Aug 2023 Common Stock 47,952 $66.97 Direct F4
holding TECH Restricted Stock Units 4,980 05 Aug 2023 Common Stock 4,980 Direct F2, F5
holding TECH Stock Option (Right to Buy) 19,456 05 Aug 2023 Common Stock 19,456 $120.46 Direct F5
holding TECH Stock Option (Right to Buy) 25,944 05 Aug 2023 Common stock 25,944 $120.46 Direct F6
holding TECH Restricted Stock Units 6,984 05 Aug 2023 Common Stock 6,984 Direct F2, F7
holding TECH Stock Options (Right to Buy) 21,704 05 Aug 2023 Common Stock 21,704 $94.52 Direct F7
holding TECH Stock Options (Right to Buy) 28,940 05 Aug 2023 Common Stock 28,940 $94.52 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3 On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs.
F4 Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F5 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
F7 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.

Remarks:

On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split.